ArticleFrontiers in medicine2022

Case Report: Heterogeneity of Resistance Mechanisms in Different Lesions Co-Mediate Acquired Resistance to First-Line Icotinib in EGFR Mutant Non-Small Cell Lung Cancer.

Zhicong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.